Felice Bombaci

Asciminib in Newly Diagnosed Chronic Myeloid Leukemia

Andreas Hochhaus, Jianxiang Wang, Dong‐Wook Kim et al. · New England Journal of Medicine · 2024 · 139 citations

Medicine, Oncology, Pharmacology +8

Factors influencing adherence in CML and ways to improvement: Results of a patient-driven survey of 2546 patients in 63 countries

Giora Sharf, Felice Bombaci, Mina Daban et al. · Journal of Cancer Research and Clinical Oncology · 2017 · 91 citations · Full text

Pharmacy, Health Sciences, Health Care Compliance +9

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24

Fabio Efficace, Michele Baccarani, Massimo Breccia et al. · Quality of Life Research · 2013 · 79 citations

Pharmacy, Oncology, Health Assessment +15

Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs

Giora Sharf, Celia Cuenca Marín, Zack Pemberton‐Whiteley et al. · Leukemia · 2020 · 58 citations · Full text

Nursing, Oncology, Behavioral Health +16

Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial

Jörge E. Cortes, Andreas Hochhaus, Naoto Takahashi et al. · Future Oncology · 2022 · 15 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11